Australia's most trusted
source of pharma news
Sunday, 25 January 2026
Posted 23 January 2026 PM
Our top story this week revealed the most valuable brand in pharma with Johnson & Johnson taking the crown for the seventh year in a row with a brand value almost double that of its closest rival.
There has been a shake-up in the rankings this year with Eli Lilly moving up three spots to claim second place and Roche slipping to bronze. See how other pharma's ranked in: Pharma's most valuable brand

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.